Comprehensive Evaluation of Quality Indicators: Analyzing the Dutch Breast Cancer Audit
International Journal of Health Policy and Management · 2025-10-01 · 14 · 8943
DOI: 10.34172/ijhpm.8943 ↗Abstract
Background: Quality indicators (QIs) are widely used to benchmark hospital performance and improve quality of care but are often based on expert opinion rather than data-driven assessment. This study aims to evaluate QIs, using a framework that assesses four criteria: Feasibility, discriminative ability, validity, and reliability. Methods: We used data from the Dutch breast cancer registry (NABON Breast Cancer Audit, NBCA) and included all surgically treated breast cancer patients in the Netherlands between 2021-2023. Eighteen QIs were evaluated. Feasibility was determined by QI numerator completeness, with >90% data availability considered feasible. Discriminative ability was assessed by between-hospital variation in QI scores, where an interquartile range (IQR) >10% indicated good discrimination. Validity was evaluated by the impact of case-mix adjustment and considered low when (pseudo-) R² 75% was considered high. Results: After exclusion of one QI with feasibility
EUVIMED